These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34267570)

  • 1. Profiling the Genetic and Molecular Characteristics of Glanzmann Thrombasthenia: Can It Guide Current and Future Therapies?
    Nurden A
    J Blood Med; 2021; 12():581-599. PubMed ID: 34267570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models.
    Nurden AT; Fiore M; Nurden P; Pillois X
    Blood; 2011 Dec; 118(23):5996-6005. PubMed ID: 21917754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the genetic basis of Glanzmann thrombasthenia: implications for treatment.
    Nurden AT; Pillois X; Nurden P
    Expert Rev Hematol; 2012 Oct; 5(5):487-503. PubMed ID: 23146053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutations.
    Sandrock-Lang K; Oldenburg J; Wiegering V; Halimeh S; Santoso S; Kurnik K; Fischer L; Tsakiris DA; Sigl-Kraetzig M; Brand B; Bührlen M; Kraetzer K; Deeg N; Hund M; Busse E; Kahle A; Zieger B
    Thromb Haemost; 2015 Apr; 113(4):782-91. PubMed ID: 25373348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanding the Mutation Spectrum Affecting αIIbβ3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort.
    Nurden AT; Pillois X; Fiore M; Alessi MC; Bonduel M; Dreyfus M; Goudemand J; Gruel Y; Benabdallah-Guerida S; Latger-Cannard V; Négrier C; Nugent D; Oiron RD; Rand ML; Sié P; Trossaert M; Alberio L; Martins N; Sirvain-Trukniewicz P; Couloux A; Canault M; Fronthroth JP; Fretigny M; Nurden P; Heilig R; Vinciguerra C
    Hum Mutat; 2015 May; 36(5):548-61. PubMed ID: 25728920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutations of integrin αIIb and β3 genes in Turkish children with Glanzmann's thrombasthenia.
    Tokgoz H; Torun Ozkan D; Caliskan U; Akar N
    Platelets; 2015; 26(8):779-82. PubMed ID: 25734216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two homozygous missense mutations in ITGB3 gene as a cause of Glanzmann Thrombasthenia in four consanguineous Pakistani pedigrees.
    Ali T; Gul S; Amar A; Shakoor M; Farhan S; Mohsin S; Khaliq S
    Int J Lab Hematol; 2020 Oct; 42(5):628-635. PubMed ID: 32558238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico analysis of structural modifications in and around the integrin αIIb genu caused by ITGA2B variants in human platelets with emphasis on Glanzmann thrombasthenia.
    Pillois X; Peters P; Segers K; Nurden AT
    Mol Genet Genomic Med; 2018 Mar; 6(2):249-260. PubMed ID: 29385657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glanzmann thrombasthenia: state of the art and future directions.
    Nurden AT; Pillois X; Wilcox DA
    Semin Thromb Hemost; 2013 Sep; 39(6):642-55. PubMed ID: 23929305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glanzmann thrombasthenia-like syndromes associated with Macrothrombocytopenias and mutations in the genes encoding the αIIbβ3 integrin.
    Nurden AT; Pillois X; Fiore M; Heilig R; Nurden P
    Semin Thromb Hemost; 2011 Sep; 37(6):698-706. PubMed ID: 22102273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal cytoplasmic extensions associated with active αIIbβ3 are probably the cause for macrothrombocytopenia in Glanzmann thrombasthenia-like syndrome.
    Hauschner H; Mor-Cohen R; Messineo S; Mansour W; Seligsohn U; Savoia A; Rosenberg N
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):302-8. PubMed ID: 25806962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glanzmann Thrombasthenia: Perspectives from Clinical Practice on Accurate Diagnosis and Optimal Treatment Strategies.
    Mathews N; Rivard GE; Bonnefoy A
    J Blood Med; 2021; 12():449-463. PubMed ID: 34149292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel homozygous silent mutation of
    Wang Z; Xu Y; Sun Y; Wang S; Dong M
    Front Pediatr; 2022; 10():1062900. PubMed ID: 36704147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A unique phenotype of acquired Glanzmann thrombasthenia due to non-function-blocking anti-αIIbβ3 autoantibodies.
    Akuta K; Kashiwagi H; Yujiri T; Nishiura N; Morikawa Y; Kato H; Honda S; Kanakura Y; Tomiyama Y
    J Thromb Haemost; 2019 Jan; 17(1):206-219. PubMed ID: 30388316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired Glanzmann thrombasthenia: From antibodies to anti-platelet drugs.
    Nurden AT
    Blood Rev; 2019 Jul; 36():10-22. PubMed ID: 31010659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glanzmann thrombasthenia: genetic basis and clinical correlates.
    Botero JP; Lee K; Branchford BR; Bray PF; Freson K; Lambert MP; Luo M; Mohan S; Ross JE; Bergmeier W; Di Paola J;
    Haematologica; 2020 Apr; 105(4):888-894. PubMed ID: 32139434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glanzmann Thrombasthenia in Pakistani Patients: Identification of 7 Novel Pathogenic Variants in the Fibrinogen Receptor αIIbβ3.
    Siddiqi MYJ; Boeckelmann D; Naz A; Imran A; Ahmed S; Najmuddin A; Zieger B
    Cells; 2023 Jan; 12(2):. PubMed ID: 36672149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Insights Into the Treatment of Glanzmann Thrombasthenia.
    Poon MC; Di Minno G; d'Oiron R; Zotz R
    Transfus Med Rev; 2016 Apr; 30(2):92-9. PubMed ID: 26968829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homozygous point mutations in platelet glycoprotein ITGA2B gene as cause of Glanzmann thrombasthenia in 2 families.
    Sandrock K; Halimeh S; Wiegering V; Kappert G; Sauer K; Deeg N; Busse E; Zieger B
    Klin Padiatr; 2012 Apr; 224(3):174-8. PubMed ID: 22513797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the platelet proteome in type I Glanzmann thrombasthenia caused by different homozygous delG frameshift mutations in ITGA2B.
    Loroch S; Trabold K; Gambaryan S; Reiß C; Schwierczek K; Fleming I; Sickmann A; Behnisch W; Zieger B; Zahedi RP; Walter U; Jurk K
    Thromb Haemost; 2017 Feb; 117(3):556-569. PubMed ID: 28078347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.